MR

Moderna, Inc. stock research

Mar 31, 2025

FY2025 Q1

Moderna (MRNA) Gross Margin — Quarter Ended Mar 31, 2025

Revenue and gross profit both decreased compared to the prior quarter and the same quarter last year, while cost of revenue declined less proportionally. Gross margin weakened from both comparison periods, reflecting a lower share of revenue retained as gross profit.

Gross margin takeaway

Quarter ended Mar 31, 2025 · FY2025 Q1

Revenue and gross profit both decreased compared to the prior quarter and the same quarter last year, while cost of revenue declined less proportionally. Gross margin weakened from both comparison periods, reflecting a lower share of revenue retained as gross profit.

  • The relationship between revenue and cost of revenue drove the margin change: revenue fell sharply while cost of revenue declined by a smaller amount, compressing gross profit. This pattern was consistent in both sequential and year-over-year comparisons.
  • Compared to the immediately preceding quarter, revenue and gross profit were lower, and gross margin weakened. Versus the same quarter one year earlier, revenue was lower, gross profit was lower, and gross margin also weakened.

Gross margin snapshot

The selected quarter's reported revenue, gross profit, direct costs, and margin comparisons.

Gross margin

16.7%

Gross profit

$18.0M

Revenue

$108.0M

Cost of revenue

$90.0M

Quarter-over-quarter change

-6.8 pts

Year-over-year change

-25.8 pts

Quarterly gross margin trend

A four-quarter view of the revenue and direct-cost bridge behind gross margin.

PeriodRevenueGross profitCost of revenueGross margin
Jun 30, 2024$241.0M$126.0M$115.0M52.3%
Sep 30, 2024$1.9B$1.3B$514.0M72.4%
Dec 31, 2024$966.0M$227.0M$739.0M23.5%
Mar 31, 2025$108.0M$18.0M$90.0M16.7%

Quarterly comparisons

Compare the selected margin with the preceding quarter and the same fiscal quarter one year earlier.

Previous-quarter change

Dec 31, 2024

-6.8 pts

Year-over-year change

Mar 31, 2024

-25.8 pts

What the margin says

Filing-constrained interpretation of margin direction, comparisons, and what to monitor next.

The relationship between revenue and cost of revenue drove the margin change: revenue fell sharply while cost of revenue declined by a smaller amount, compressing gross profit. This pattern was consistent in both sequential and year-over-year comparisons.

Compared to the immediately preceding quarter, revenue and gross profit were lower, and gross margin weakened. Versus the same quarter one year earlier, revenue was lower, gross profit was lower, and gross margin also weakened.

Monitor the trajectory of cost of revenue relative to revenue, as its slower decline has been the primary factor in margin compression.

MRNA Gross Margin — Quarter Ended Mar 31, 2025